Form 4: RxSight Executive Ilya Goldshleger Executes Stock Option and Sells Shares Under 10b5-1 Plan

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On October 30, 2024, Ilya Goldshleger, Co-President and Chief Operating Officer of RxSight, Inc., executed a stock option to acquire 3,105 shares of common stock at a price of $15.08 per share.
• Simultaneously, Goldshleger sold 3,105 shares of RxSight common stock at a weighted average price of $51.9069, within a price range of $51.57 to $52.18.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted by Goldshleger on June 3, 2024.
• Following these transactions, Goldshleger directly owns 42,246 shares of RxSight common stock and indirectly owns 1,372 shares through a spouse.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives, which is important for investors to assess management's confidence in the company's prospects. The use of a 10b5-1 plan indicates a pre-arranged strategy to avoid accusations of trading on inside information.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.
• The disclosure provides transparency to stakeholders regarding insider trading activities.

Key Dates